查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540873

2024-2032 年按產品類型、應用類型、應用、最終用戶和地區分類的臉部注射劑市場報告

Facial Injectables Market Report by Product Type, Application Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球臉部注射市場規模達到85億美元。人口老化、個人對非侵入性解決方案的需求不斷成長以及名人代言和社交媒體的影響推動了全球美容療程的需求，推動了臉部注射市場的發展。

臉部注射劑市場分析：

主要市場促進因素：對微創整容手術的需求不斷成長、面部美容意識不斷增強以及老年人口希望顯得年輕，推動了市場成長。

主要市場趨勢：由於肉毒桿菌和皮膚填充劑等非手術程序的效率和最少的停機時間，對它們的需求正在增加。在臉部注射劑市場預測中，由於人們越來越渴望獲得自然效果並為患者提供有效、安全的客製化治療，該行業將見證多樣化產品配方和應用選項的不斷創造。

地理趨勢：由於可支配收入高、醫療基礎設施發達以及美容治療的廣泛採用，北美成為最大的市場。其他潛在市場包括亞太和歐洲，這些地區居民的收入不斷增加，隨之而來的是嚴格的法規，以及數百家提供注射治療的美容診所。

競爭格局：臉部注射劑行業的一些主要市場參與者包括 Allergan Plc、Anika Therapeutics Inc.、Bloomage BioTechnology、Johnson & Johnson、Galderma Pharma SA、Integra LifeSciences、Ipsen (Mayroy SA)、Medytox Inc.、Merz Holding GmbH & Co Co . KG、Prollenium Medical Technologies Inc.、賽諾菲、SciVision Biotech Inc.、Sinclair Pharma（華東醫藥股份有限公司）、Suneva Medical Inc. 和Bausch Health Companies Inc. 等。

挑戰與機會：監管障礙和安全問題給市場參與者帶來了挑戰，需要嚴格遵守品質標準並與消費者進行透明溝通。如同臉部注射市場概述中所述，向新興經濟體和男性美容手術等未開發市場的擴張，為傳統細分市場競爭加劇和市場飽和提供了成長途徑。

臉部注射劑市場趨勢：

人口老化加劇：

隨著全球人口老化，對臉部注射劑的需求不斷增加。雖然它們很重要，但老化會帶來各種明顯的跡象，如皺紋、細紋和皮膚下垂。因此，人們總是選擇美容療程來保持年輕的外表。由於零停機時間和非手術程序，臉部注射鼓勵廣大受眾詢問如何在不接受侵入性治療的情況下自我恢復活力。此外，已開發國家的年齡層正在擴大，人們現在更加關心自己的外表。因此，他們願意尋求美容治療，以達到最佳的外觀和感覺，從而影響臉部注射劑的市場前景。根據世界衛生組織的數據，2020 年，全球 60 歲及以上人口超過了 5 歲以下兒童。全球老化人口預計將加倍，從 2015 年的 12% 增加到 2050 年的 22%。

對非侵入性手術的需求不斷成長

人們選擇非侵入性臉部整形手術是因為其方便、停機時間短、風險低、副作用少。例如，真皮填充劑和肉毒桿菌注射劑可以為許多常見的美容問題（如皺紋、體積減少和臉部不對稱）提供快速有效的解決方案。此外，忙碌的生活和技術進步使許多手術變得高效且危險性降低，影響了新一代非侵入性面部治療，從而增加了臉部注射劑的市場價值。美國整形外科醫師協會（ASPS）的數據顯示，2022年美國總共進行了2,620萬例手術和微創整容及重建治療。數量。

名人代言與社群媒體影響力

美容標準和消費者偏好受到名人代言和社群媒體人物的影響，這推動了臉部注射劑市場的成長。當名人公開討論他們的臉部整形手術或在各種社交媒體網站上發布相關資訊時，他們的追隨者更有可能考慮使用臉部注射劑。例如，根據美國臉部整形與重建外科學會 (AAFPRS) 的調查，自 2019 年以來，臉部整形外科醫生的整容手術增加了 90%。手術的外科醫生。鼻子整形手術或鼻整形手術則位居第二，外科醫師進行的手術佔 79%，而眼瞼整形手術或眼部整形手術則佔 73%。對男女來說，前三名的外科手術是鼻整形手術，佔 83%，眼瞼整形術佔 49%，臉部除皺和局部除皺術佔 48%。

臉部注射劑市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、應用程式類型、應用程式和最終用戶對市場進行了分類。

按產品類型分類：

膠原

透明質酸 (HA)

A型肉毒桿菌毒素

羥基磷灰石鈣 (CaHA)

聚甲基丙烯酸甲酯珠（PMMA微球）

聚左旋乳酸 (PLLA)

其他

A型肉毒桿菌素佔據大部分市場佔有率

該報告根據產品類型對市場進行了詳細的細分和分析。其中包括膠原蛋白、透明質酸 (HA)、A 型肉毒桿菌毒素、羥基磷灰石鈣 (CaHA)、聚甲基丙烯酸甲酯珠（PMMA 微球）、聚 L-乳酸 (PLLA) 等。根據該報告，A 型肉毒桿菌毒素佔最大部分。

A 型肉毒桿菌毒素佔最大佔有率，因為它廣泛用於解決多種美容問題，包括皺紋、細紋和臉部不對稱。 A 型肉毒桿菌注射（例如 Botox、Dysport 和 Xeomin）可透過放鬆臉部肌肉並確保皮膚更光滑、更年輕，提供複雜的臨時解決方案。目前，消費者對微創美容手術的需求持續成長，推動了現有產品線的生產。例如，2024年3月，Croma的韓國毒素產品製造商和合作夥伴Hugel獲得美國食品藥物管理局批准Letybo(R)（LetibotulinumtoxinA）用於治療成人眉間紋。

按應用程式類型細分：

美學

療法

美學佔據產業最大佔有率

報告還根據應用程式類型提供了詳細的市場細分和分析。這包括美學和治療學。報告顯示，美容佔據了最大的市場。

美容部分包括改善臉部整體外觀和解決老化跡象的整容手術。隨著注射技術支援的美容文化的興起，為患者提供安全有效的微創治療成為可能，越來越多的人選擇接受此類手術。根據美國整形外科醫生協會 (ASPS) 的數據，整容手術增加了 8%。國際美容整形外科學會2022年進行的調查結果顯示，美容手術呈現持續成長趨勢，近四年大幅增加41.3%。因此，臉部除皺手術的增加促進了臉部注射劑市場的成長。

按應用分類：

臉部線條矯正

豐唇術

臉部提升

痤瘡疤痕治療

其他

該報告根據應用程式提供了詳細的市場細分和分析。這包括臉部線條矯正、豐唇、臉部提升、痤瘡疤痕治療等。

臉部注射通常用於矯正臉部皮膚的細紋、皺紋和深層皺紋，讓患者看起來更清新、更光滑。適用區域包括前額、眼部魚尾紋、法令紋等，確保自然效果，賦予臉部年輕曲線。

注射填充劑也可用於豐唇，以增加唇部尺寸、賦予其形狀並保持與臉部的和諧比例。有時，患者會使用填充劑來獲得更飽滿的外觀，糾正因老化而造成的口紅皺紋，或改善嘴唇的形狀和比例。根據國際美容整形外科學會 (ISAPS) 的數據，2022 年抽脂手術是最常見的外科手術，手術量超過 230 萬例，增加了 21.1%。

此外，填充劑可以以非侵入性的方式重現與手術類似的效果。這只是臉部任何區域的體積增加，導致下巴、臉頰或太陽穴區域出現缺陷並隨後下垂。填充注射劑可以使臉部外觀提拉、恢復活力，同時降低術後併發症的風險並加快患者的恢復時間。除此之外，注射填充劑也用於糾正凹陷性痤瘡疤痕並恢復許多人的信心。

按最終用戶分類：

醫院

皮膚科診所

其他

醫院在市場上表現出明顯的主導地位

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院、皮膚科診所等。報告顯示，醫院佔據了最大的市場。

該醫院經常充當各種醫療和美容手術的一站式場所，為臉部注射提供便利。由於醫院的便利性和可信度，這些機構吸引了廣泛的患者。尋求專業護理和技能的患者可以輕鬆地在醫院獲得服務。國際美容整形外科學會 (ISAPS) 的一份報告顯示，2022 年整形外科醫生實施的手術總數為 11.2%，其中涉及全球 1,490 萬例手術和 1,880 萬例非手術程序。隨著人們接受手術修復程序，醫院滿足了許多人對美容治療的需求，從而產生了臉部注射劑市場收入。醫院擁有充足且先進的工具以及訓練有素的專業人員來進行臉部注射。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的臉部注射市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是臉部注射劑最大的區域市場。

根據臉部注射劑市場研究，北美由於多種原因主導市場，導致其強勁成長。這主要是由於大量老齡化人口、高可支配收入、先進的醫療設施以及一些人保持年輕和美麗的壓力。此外，主要參與者的持續創新和技術進步維持了市場的擴張。 2023 年 5 月，Evolus, Inc. 是一家為消費者提供具有卓越體驗的創新產品的功能性美容組織，在美國簽訂了五種處於高級開發階段的新型真皮填充劑的獨家經銷協議。

競爭格局：

臉部注射劑市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。臉部注射劑產業的一些主要市場參與者包括 Allergan Plc、Anika Therapeutics Inc.、Bloomage BioTechnology、Johnson & Johnson、Galderma Pharma SA、Integra LifeSciences、Ipsen (Mayroy SA)、Medytox Inc.、Merz Holding GmbH & Co.。 、Prollenium Medical Technologies Inc.、賽諾菲、SciVision Biotech Inc.、Sinclair Pharma（華東醫藥股份有限公司）、Suneva Medical Inc. 和Bausch Health Companies Inc.

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

臉部注射劑市場的主要參與者正在採取重要措施以確保該行業的成長。因此，艾爾建 (Allergan)、高德美 (Galderma)、隆泰 (Longtai) 和辛克萊 (Sinclair) 等公司透過開發新配方確保了自己擁有廣泛的產品組合。他們還透過與醫療器材公司簽訂協議和建立合作夥伴關係來擴大市場範圍。促銷計劃將有助於提高消費者對使用臉部注射劑好處的認知，從而使注射劑子行業受益。例如，Galderma 在達拉斯推出了FACE by Galderma(TM)，將其設想為一種由擴增實境(AR) 驅動的先進美容可視化工具，這項創新舉措使美容專家和患者能夠在手術前預測注射治療的結果。 Galderma 旨在提供每根針頭所能達到的範圍的模擬前後影像，並有望減輕患者對注射結果的焦慮。

臉部注射劑市場新聞：

2024 年3 月：艾伯維(AbbVie) 旗下公司Allergan Aesthetics 宣布，美國食品藥物管理局(FDA) 已批准JUVEDERM(R) VOLUMA(R) XC 透明質酸(HA) 填充劑注射到一名中度至中度患者的太陽穴中21 歲以上成年人嚴重的太陽穴空洞。

2023年10月：華東醫藥股份有限公司全資子公司Sinclair Pharma Details宣布與ATGC Pharmacological Research結成策略夥伴關係，建立合理的許可安排。 Sinclair 已獲得生產和商業化 ATGC 肉毒毒素產品 ATGC-110 的獨家權利，ATGC-110 是尖端 A 型肉毒毒素，正在進行臨床開發，用於暫時增強中度至重度眉間外觀。它已獲得全球獨家授權（不包括印度和韓國）。

本報告回答的關鍵問題

  • 全球臉部注射劑市場成長如何
  • 全球臉部注射劑市場促進因素是什麼
  • 全球臉部注射劑市場的主要行業趨勢是什麼
  • COVID-19對全球臉部注射劑市場有何影響
  • 全球臉部注射劑市場按產品類型分類是怎樣的
  • 全球臉部注射劑市場按應用類型分類是怎樣的
  • 全球臉部注射劑市場最終用戶的細分如何
  • 全球臉部注射劑市場主要有哪些地區
  • 全球臉部注射劑市場的主要公司/參與者有哪些

本報告回答的關鍵問題

  • 全球臉部注射劑市場成長情況如何？全球臉部注射劑市場促進因素是什麼？
  • 全球臉部注射劑市場的主要行業趨勢是什麼？
  • COVID-19 對全球臉部注射劑市場有何影響？
  • 按產品類型分類的全球臉部注射劑市場細分是多少？
  • 全球臉部注射劑市場按應用類型分類是怎樣的？
  • 全球臉部注射劑市場最終用戶的詳細情形如何？
  • 全球臉部注射劑市場的主要地區有哪些？
  • 全球臉部注射劑市場的主要公司/參與者有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球臉部注射劑市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 膠原
    • 市場趨勢
    • 市場預測
  • 透明質酸 (HA)
    • 市場趨勢
    • 市場預測
  • A型肉毒桿菌毒素
    • 市場趨勢
    • 市場預測
  • 羥基磷灰石鈣 (CaHA)
    • 市場趨勢
    • 市場預測
  • 聚甲基丙烯酸甲酯珠（PMMA微球）
    • 市場趨勢
    • 市場預測
  • 聚左旋乳酸 (PLLA)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用類型

  • 美學
    • 市場趨勢
    • 市場預測
  • 療法
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 臉部線條矯正
    • 市場趨勢
    • 市場預測
  • 豐唇術
    • 市場趨勢
    • 市場預測
  • 臉部提升
    • 市場趨勢
    • 市場預測
  • 痤瘡疤痕治療
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 皮膚科診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allergan Plc
    • Anika Therapeutics Inc.
    • Bloomage BioTechnology
    • Johnson & Johnson
    • Galderma Pharma SA
    • Integra LifeSciences
    • Ipsen (Mayroy SA)
    • Medytox Inc.
    • Merz Holding GmbH & Co. KG
    • Prollenium Medical Technologies Inc.
    • Sanofi
    • SciVision Biotech Inc.
    • Sinclair Pharma (Huadong Medicine Co. Ltd.)
    • Suneva Medical Inc.
    • Bausch Health Companies Inc.
Product Code: SR112024A2814

The global facial injectables market size reached US$ 8.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032. The facial injectables market is driven by the growing aging population, and the increasing demand for non-invasive solutions among individuals, and celebrity endorsements and social media influence driving demand for aesthetic treatments worldwide.

Facial Injectables Market Analysis:

Major Market Drivers: The market growth is propelled by the increasing demand for minimally invasive cosmetic procedures, increasing awareness of facial aesthetics, and the desire of the aging population to appear youthful.

Key Market Trends: The demand for non-surgical procedures such as Botox and dermal fillers is increasing as a result of their efficiency and minimal level of downtime. In the facial injectables market forecast, the industry will witness the ongoing creation of diverse product formulations and application options influenced by the increased desire to attain natural-looking results and to offer patients treatments that are effective safe customized.

Geographical Trends: North America is the largest market due to high disposable income, well-developed healthcare infrastructure, and widespread adoption of aesthetic treatments. Other potential markets include Asia-Pacific and Europe, where residents' income is increasing, followed by stringent regulations, and hundreds of aesthetic clinics providing injectable treatment.

Competitive Landscape: Some of the major market players in the facial injectables industry include Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc. among many others.

Challenges and Opportunities: The regulatory hurdles and safety concerns pose challenges for market players, necessitating stringent compliance with quality standards and transparent communication with consumers. As outlined in the facial injectables market overview, eexpansion into untapped markets, such as emerging economies and male aesthetic procedures, offers avenues for growth amidst intensifying competition and market saturation in traditional segments.

Facial Injectables Market Trends:

Increasing Aging Population:

As the global population is aging the demand for facial injectables is rising. While they are essential, aging comes with various visible signs like wrinkles, fine lines, and sagging skin. Thus, individuals always opt for aesthetic treatments to keep a youthful appearance. Due to the zero downtime and non-surgical procedure, facial injectables encourage a wide audience inquiring about self-rejuvenation without undergoing invasive treatments. Furthermore, the age sector in developed countries is expanding, and people now care more about their appearance. Hence, they are willing to seek aesthetic treatments to look and feel their best, influencing the facial injectables market outlook. In 2020, the global population aged 60 years and above exceeded the under-five children, according to the World Health Organization. The aging population is expected to double globally from 12% in 2015 to 22% in 2050.

Rising Demand for Non-Invasive Procedures

Individuals are opting for non-invasive facial plastic procedures owing to their convenience, minimal downtime decreased risk, and fewer side effects. For example, dermal fillers and botulinum toxin injections, are injectables that provide quick and efficient solutions to numerous common aesthetic problems like wrinkles, volume depletion, and facial asymmetry. Moreover, busy lives, and technological advances that make many procedures efficient and less dangerous, influence the new generation of non-invasive face treatments, which is increasing the facial injectables market value. Data from the American Society of Plastic Surgeons (ASPS) reveals that a total of 26.2 million surgical and minimally invasive cosmetic and reconstructive treatments were performed in the United States in 2022. It also reveals that 19% of cosmetic surgeries surged since 2019, increasing the facial injectables market demand.

Celebrity Endorsements and Social Media Influence

Beauty standards and consumer preferences are influenced by celebrity endorsements and social media personalities which is driving the facial injectables market growth. When celebrities openly discuss their facial plastic surgeries or post about them on various social media sites, their followers are more likely to consider using facial injectables. For instance, according to the survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), facial plastic surgeons have reported a 90% rise in facelifts since 2019. Last year, facelifts were the leading surgical procedure for females, with 86% of surgeons performing them. Noses jobs or rhinoplasty come second, with surgeons performing them on 79%, while blepharoplasty or eye lift stood at 73%. For both genders, the top three surgical procedures are rhinoplasty accounting for 83%, blepharoplasties at 49%, and facelifts and partial facelifting at 48%.

Facial Injectables Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application type, application, and end user.

Breakup by Product Type:

Collagen

Hyaluronic Acid (HA)

Botulinum Toxin Type A

Calcium Hydroxylapatite (CaHA)

Polymethylmethacrylate Beads (PMMA Microspheres)

Poly-L-Lactic Acid (PLLA)

Others

Botulinum toxin type A accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes collagen, hyaluronic acid (HA), botulinum toxin type A, calcium hydroxylapatite (CaHA), polymethylmethacrylate beads (PMMA microspheres), poly-l-lactic acid (PLLA), and others. According to the report, botulinum toxin type A represented the largest segment.

Botulinum toxin type A comprises the largest segment due to its wide use to address several cosmetic concerns, including wrinkles, fine lines, and facial asymmetry. Botulinum toxin type A injections, such as Botox, Dysport, and Xeomin, provide a sophisticated, temporary solution by relaxing facial muscles and ensuring smoother and younger-looking skin. Currently, consumer demand for minimally invasive cosmetic procedures continues to rise driving the production of existing product lines. For example, in March 2024, Croma's Korean toxin product manufacturer and partner Hugel was approved by the U.S. Food and Drug Administration for Letybo(R) (LetibotulinumtoxinA) to treat glabellar lines in adults.

Breakup by Application Type:

Aesthetics

Therapeutics

Aesthetics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application type have also been provided in the report. This includes aesthetics and therapeutics. According to the report, aesthetics accounted for the largest market share.

The aesthetic segment includes cosmetic procedures to improve the overall appearance of the face and address signs of aging. With the rise of beauty cultures supported by injectable technologies, which made it possible to offer safe and effective minimally invasive treatments to the patient, more people have opted to undergo such procedures. As per the American Society of Plastic Surgeons (ASPS), facelifts grew by 8%. The survey conducted in 2022 by the International Society of Aesthetic Plastic Surgery presents such results that the trends showed a continued increase in aesthetic surgery, with a significant increase of 41.3% in the last four years. As a result, the increasing facelift procedures are contributing to the facial injectables market growth.

Breakup by Application:

Facial Line Correction

Lip Augmentation

Face Lift

Acne Scar Treatment

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes facial line correction, lip augmentation, face lift, acne scar treatment, and others.

Facial injectables are commonly used for correcting fine lines, wrinkles, and deep creases in the facial skin to give the patient a fresher and smoother look. Areas of application include the forehead, crow's feet in the eye region, and nasolabial folds, among others, ensuring a natural result that gives the face its youthful curves.

Injectable fillers are also used in lip augmentation to increase the size, give it shape, and maintain a harmonic proportion with the face. Sometimes patients use fillers to get a fuller look, to correct lipstick creases due to aging, or to give better shape and proportion to the lip. Liposuction was the most common surgical procedure according to the International Society of Aesthetic Plastic Surgery (ISAPS) in 2022, with more than 2.3 million procedures and a 21.1% expansion.

Additionally, fillers can recreate a similar effect as surgery in a non-invasive way. This simply an increase in volume in any area of the face that has undergone a deficit and subsequent sagging in the jaw, cheek, or temple areas. Filler injectables result in a lifted and rejuvenated appearance of the face at a reduced risk of postoperative complications and a faster recovery time for the patient. Besides this, injectable fillers are also used in correcting depressed acne scars and restoring the confidence of numerous individuals.

Breakup by End User:

Hospitals

Dermatology Clinics

Others

Hospitals exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, dermatology clinics, and others. According to the report, hospitals accounted for the largest market share.

The hospital often acts as a one stop space for various medical and cosmetic procedures, facilitating facial injectables among their services. As a result of accessibility and the credibility associated with hospitals, the institutions have attracted a broad patient spectrum. Patients seeking professional care and skills easily obtain their services at a hospital. One report by the International Society of Aesthetic Plastic Surgery (ISAPS) indicated an overall 11.2% of procedures performed by plastic surgeons in 2022, involving 14.9 million surgical and 18.8 million non-surgical procedures performed all over the world. As people embrace surgery restoration procedures the hospital helps numerous individuals' needs for aesthetic treatments, thus generating facial injectables market revenue. Hospitals have adequate and sophisticated tools and well-trained professionals to administer facial injectables.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest facial injectables market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for facial injectables.

As per the facial injectables market research, North America is dominating the market for several reasons resulting in its strong growth. This is mainly due to a large aging population, high disposable income, advanced healthcare facilities, and the pressure to remain young and beautiful among several individuals. Moreover, continuous innovation and technological advancements by key players have sustained the market expansion. In May 2023, Evolus, Inc., a performance beauty organization that delivers innovative products with exceptional experiences to consumers, entered into an exclusive distribution agreement in the United States for five novel dermal fillers with advanced stages of development.

Competitive Landscape:

The facial injectables market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the facial injectables industry include Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the facial injectables market are taking vital steps to ensure the growth of the sector. As a result, companies such as Allergan, Galderma, Longtai, and Sinclair have ensured they have an extensive product portfolio by developing new formulations. They are also expanding their market reach by entering into agreements and partnerships with medical device companies. The promotional programs will help increase consumer awareness about the benefits of using facial injectables, benefiting the injectables sub-sector. For instance, Galderma, launched FACE by Galderma(TM) in Dallas envisioning it as an advanced aesthetic visualization tool driven by augmented reality (AR), the inventive initiative enables aesthetic experts and patients to foretell injectable treatment results even before the procedure. Galderma aims to provide a simulated before and after image of what the scope of each needle can achieve and hopefully alleviate patient anxieties concerning injectable outcomes.

Facial Injectables Market News:

March 2024: Allergan Aesthetics, an AbbVie company, announced that the U.S. FOOD and DRUG ADMINISTRATION (FDA) had approved JUVEDERM(R) VOLUMA(R) XC hyaluronic acid (HA) filler to inject into the temple of a patient identified for moderate to severe temple hollowing in adults over the age of 21. This is the sole HA filler that the FDA has authorized with optimal treatment that is clinically documented to endure up to 13 months.

October 2023: Sinclair Pharma Details, a wholly owned subsidiary of Huadong Medicine Co., Ltd., declared the formation of a strategic partnership with ATGC Pharmacological Research to establish a rational licensing arrangement. Sinclair has been granted exclusive rights to manufacture and commercialize ATGC's botulinum toxin product, ATGC-110, cutting-edge botulinum toxin type A, undergoing clinical development for temporarily enhanced glabellar appearances at moderate to severe levels. It has been exclusively licensed globally (excluding India and South Korea).

Key Questions Answered in This Report

  • 1. What is the global facial injectables market growth?
  • 2. What are the global facial injectables market drivers?
  • 3. What are the key industry trends in the global facial injectables market?
  • 4. What is the impact of COVID-19 on the global facial injectables market?
  • 5. What is the global facial injectables market breakup by product type?
  • 6. What is the global facial injectables market breakup by application type?
  • 7. What is the global facial injectables market breakup by end user?
  • 8. What are the major regions in the global facial injectables market?
  • 9. Who are the key companies/players in the global facial injectables market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Facial Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Collagen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hyaluronic Acid (HA)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Botulinum Toxin Type A
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Calcium Hydroxylapatite (CaHA)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Poly-L-Lactic Acid (PLLA)
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application Type

  • 7.1 Aesthetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Facial Line Correction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lip Augmentation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Face Lift
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Acne Scar Treatment
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Dermatology Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Bloomage BioTechnology
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Galderma Pharma S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Integra LifeSciences
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ipsen (Mayroy SA)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medytox Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Merz Holding GmbH & Co. KG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Prollenium Medical Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 SciVision Biotech Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
    • 15.3.14 Suneva Medical Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
    • 15.3.15 Bausch Health Companies Inc.
      • 15.3.15.1 Company Overview
      • 15.3.15.2 Product Portfolio
      • 15.3.15.3 Financials
      • 15.3.15.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
  • Figure 2: Global: Facial Injectables Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2023
  • Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2023
  • Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Facial Injectables Industry: SWOT Analysis
  • Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
  • Figure 94: Global: Facial Injectables Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million US$), 2024-2032
  • Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Facial Injectables Market Structure
  • Table 8: Global: Facial Injectables Market: Key Players